Abstract
The diagnosis of prostate carcinoma, especially when present in a limited amount in biopsy, is often challenging because numerous benign conditions have architectural and cytological features overlapping with and mimicking carcinoma. These mimics include various anatomic structures, inflammatory and reactive conditions, and pathophysiological conditions, including atrophy, hyperplasia, and metaplasia. Many of these lesions are readily recognized and separated from malignancy, but some may cause potential diagnostic difficulties.
A useful approach to classifying benign mimics is based on major growth patterns of prostate carcinoma outlined in the Gleason grading system. This approach provides a conceptual framework for considering differential diagnoses. Three major growth patterns are encountered: small well-formed gland pattern mimicking Gleason pattern 3 carcinomas; cribriform growth pattern mimicking Gleason pattern 4 carcinomas; and poorly formed/fused gland/nest/single cell pattern mimicking Gleason pattern 4 or 5 carcinomas. Most benign lesions mimic small gland (acinar) adenocarcinoma; however, mixture of growth patterns is also commonly encountered.
Before establishing a cancer diagnosis, pathologists should always consider and rule out various benign lesions that mimic carcinoma. Immunohistochemical markers should be utilized to support the morphological impression, and one should be aware about pitfalls and limitations of markers. This chapter outlines an overall approach, classification, description of pathologic features, and diagnostic pitfalls of each benign entity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Algaba F, Trias I. Mimickers of prostate cancer in needle biopsies. Anal Quant Cytopathol Histpathol. 2015;37:57–64.
Hameed O, Humphrey PA. Pseudoneoplastic mimics of prostate and bladder carcinomas. Arch Pathol Lab Med. 2010;134:427–43.
Netto GJ, Epstein JI. Benign mimickers of prostate adenocarcinoma on needle biopsy and transurethral resection. Surg Pathol Clin. 2008;1:1–41.
Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod Pathol. 2004;17:328–48.
Trpkov K. Benign mimics of prostatic adenocarcinoma. Mod Pathol. 2018;31:S22–46.
Herawi M, Parwani AV, Irie J, Epstein JI. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 2005;29:874–80.
Humphrey PA. Variants of acinar adenocarcinoma of the prostate mimicking benign conditions. Mod Pathol. 2018;31:S64–70.
Brimo F, Epstein JI. Immunohistochemical pitfalls in prostate pathology. Hum Pathol. 2012;43:313–24.
Kunju LP, Rubin MA, Chinnaiyan AM, Shah RB. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations. Am J Clin Pathol. 2003;120:737–45.
Shah RB. Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management. Adv Anat Pathol. 2013;20:117–24.
Shah RB, Kunju LP, Shen R, LeBlanc M, Zhou M, Rubin MA. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol. 2004;122:517–23.
De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155:1985–92.
De Marzo AM, Platz EA, Epstein JI, Ali T, Billis A, Chan TY, et al. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006;30:1281–91.
Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol. 2001;158:1767–73.
Przybycin CG, Kunju LP, Wu AJ, Shah RB. Partial atrophy in prostate needle biopsies: a detailed analysis of its morphology, immunophenotype, and cellular kinetics. Am J Surg Pathol. 2008;32:58–64.
Lotan TL, Epstein JI. Diffuse adenosis of the peripheral zone in prostate needle biopsy and prostatectomy specimens. Am J Surg Pathol. 2008;32:1360–6.
Tian W, Dorn D, Wei S, Sanders RD, Matoso A, Shah RB, et al. GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall. Histopathology. 2017;71(1):150–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shah, R.B., Zhou, M. (2019). Benign Mimics of Prostate Carcinoma. In: Prostate Biopsy Interpretation. Springer, Cham. https://doi.org/10.1007/978-3-030-13601-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-13601-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13600-0
Online ISBN: 978-3-030-13601-7
eBook Packages: MedicineMedicine (R0)